founded BOH and developed the technology behind it an Executive manager business development professional familiar with all aspects of strategy, planning and execution of introduction and expansion plans for multiple products and services in global markets for over 30 years, focusing on the last 15 years on medical devices and pharmaceuticals in the U.S., Europe, China and Brazil. Maintained a strong network of contacts on a global level.Fluent in English, French and Hebrew. Completed Israeli military service as a captain in the Special forces in the IDF. 2018-Date CEO, NIHE Tech Ltd. NIHE manages several startup companies from inception to Series B round from idea to seed investment and Series A, POC and MVP current portfolio includes: OTX a patented optical chip for Active Optical Cables, SAAK a patented middle ear implant, BOH developing quick non invasive breath sample diagnostics for pulmonary diseases and infections, and Virexx a human friendly patented solution for long lasting anti viral, bacterial and fungi protection.2016-2018 CEO, Melamed Medical Ltd. Melamed Medical is focused on acquiring IP of pharmaceutical products and commercializing these, such as a drug that treats exposure to radiation and test kits for early diagnosis of viral related diseasesCompleted a funding round of $6 million in 2017 for the acquisition of Insight Biopharmaceutical and closed the transaction in August 20172011-2016 CEO, PCT Ltd. (Israel)Starting as a trial-stage start up, PCT grew to become the exclusive special coating company of IDE, one of the largest global desalination companies2004-2011 CEO, Greenkote (U.S. and Israel)Managed the company from its inception through its merger with IPC USACompleted fundraising through several rounds totaling $35 million, including the acquisition of IPC USAGlobal management of several companies world wide (USA, Mexico, Germany and Israel), including planning, managing, follow up, performance monitoring, board and investor relationshipsI